These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 1806588

  • 1. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
    Dolan KT, Staub JM, Schofield TL, Ahonkhai VI, Ellis RW, Vella PP.
    J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588
    [Abstract] [Full Text] [Related]

  • 2. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR, Granoff DM, Barenkamp SJ, Powers DC, Kennedy D, Irby-Moore S, Homan SM, Mink CM.
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [Abstract] [Full Text] [Related]

  • 3. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Wong VK, Quagliata R, Adler R, Kim KS.
    Am J Dis Child; 1991 Jul; 145(7):742-5. PubMed ID: 2058604
    [Abstract] [Full Text] [Related]

  • 4. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B, Wald E, Guerra N, Byers C.
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [Abstract] [Full Text] [Related]

  • 5. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
    Gray BM.
    Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
    Donnelly JJ, Deck RR, Liu MA.
    J Immunol; 1990 Nov 01; 145(9):3071-9. PubMed ID: 2120344
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA.
    Pediatrics; 1990 Apr 01; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [Abstract] [Full Text] [Related]

  • 12. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
    Santosham M, Wolff M, Reid R, Hohenboken M, Bateman M, Goepp J, Cortese M, Sack D, Hill J, Newcomer W.
    N Engl J Med; 1991 Jun 20; 324(25):1767-72. PubMed ID: 1903846
    [Abstract] [Full Text] [Related]

  • 13. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK, Daum RS.
    Pediatrics; 1990 Apr 20; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [Abstract] [Full Text] [Related]

  • 14. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
    Chotpitayasunondh T, Panpitpat C, Thisyakorn U, Furer E, Que JU, Hasler T, Cryz SJ.
    Southeast Asian J Trop Med Public Health; 1997 Mar 20; 28(1):91-8. PubMed ID: 9322290
    [Abstract] [Full Text] [Related]

  • 15. Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae.
    Weinberg GA, Granoff DM, Nahm MH, Shackelford PG.
    J Immunol; 1986 Jun 01; 136(11):4232-6. PubMed ID: 3486228
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean children.
    Lehmann D, Kakazo M, Yarsley S, Javati A, Taime J, Saleu G, Namuigi P, Alpers MP, Mendelman PM, Staub T.
    P N G Med J; 1998 Jun 01; 41(3-4):102-11. PubMed ID: 10934551
    [Abstract] [Full Text] [Related]

  • 17. Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization.
    Massó F, Paéz A, Arista A, Salmón L, Montaño L.
    Arch Med Res; 1996 Jun 01; 27(4):539-45. PubMed ID: 8987192
    [Abstract] [Full Text] [Related]

  • 18. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.
    Ahonkhai VI, Lukacs LJ, Jonas LC, Matthews H, Vella PP, Ellis RW, Staub JM, Dolan KT, Rusk CM, Calandra GB.
    Pediatrics; 1990 Apr 01; 85(4 Pt 2):676-81. PubMed ID: 2107518
    [Abstract] [Full Text] [Related]

  • 19. Effect of Haemophilus influenzae polysaccharide outer membrane protein complex conjugate vaccine on macrophages.
    Ambrosino DM, Bolon D, Collard H, Van Etten R, Kanchana MV, Finberg RW.
    J Immunol; 1992 Dec 15; 149(12):3978-83. PubMed ID: 1460286
    [Abstract] [Full Text] [Related]

  • 20. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
    Parkkali T, Käyhty H, Anttila M, Ruutu T, Wuorimaa T, Soininen A, Volin L, Ruutu P.
    Bone Marrow Transplant; 1999 Sep 15; 24(6):671-8. PubMed ID: 10490735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.